In this episode, we hear from Nate Beyor, managing director and partner of BCG healthcare. We dive into many topics around digital therapeutics and get a bird’s eye view across BCG’s customer base.
In this episode, we cover:
- New company creation: large company spin-outs vs entrepreneurs
- What it takes to build a team that can take a digital therapeutic to market
- Why build rather than buy a new DTx
- Approaching medical pharma clients vs approaching smaller DTx companies
- Go to market strategy and value creation: Standalone vs Drug+
- Embedding clinical decision support into workflows
Guest Links and Resources:
- Connect with Nate Beyor on: LinkedIn
- Visit: www.bcg.com/
Host Links:
- Connect with Eugene Borukhovich: Twitter | LinkedIn
- Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn
- Connect with YourCoach.health: Website | Twitter
- Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App
- HealthXL: Website | Twitter | Join an Event
Season 2 of Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:
> Presenting Partner: Amalgam Rx
> Contributing Sponsors: Akili | Big Health | Click Therapeutics | Lindus Health
Follow Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram
Follow Health Podcast Network:
Browse Shows | LinkedIn | Twitter | Facebook | Instagram
